BioTech Pharma
HomeCatalogThymosin Alpha-1
Thymosin Alpha-1 research vial

2D Molecular Structure

Thymosin Alpha-1 2D molecular structure for compound 16130571
CID
16130571
Standard InChIKey
NZVYCXVTEHPMHE-ZSUJOUNUSA-N
Residue Count
28 AA
Structural Modifications
  • N-terminal acetylation (Ac-Ser1)
  • C-terminal free acid (–OH)
  • No disulfide
regenerative Research

Thymosin Alpha-1

Also known as: Thymalfasin, Thymosin α1, TA1

N-acetylated 28-residue immunomodulatory peptide derived from prothymosin alpha, studied in immune-signaling and tissue-response research.
CAS Number
62304-98-7
Molecular Formula
C129H215N33O55
Molecular Weight
3108.3 g/mol
Purity
Batch-specific
Form
Lyophilized powder
Enquiry Sizes
Research vial • Bulk / custom fill (quote required)
Peptide Sequence28 residues
Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn (N-terminally acetylated)

Compliance Notice: All products supplied by BioTech Pharma are intended strictly for laboratory research and development use only. They are not intended for human or veterinary use, diagnosis, treatment, or consumption of any kind. By submitting an enquiry, the requester confirms they are a qualified researcher or institution and accepts full responsibility for compliant handling and use.

Configure Your Request

Documentation requests are reviewed against the records available for the applicable lot. Availability, methods, and values must be confirmed for the specific enquiry and are not promised in advance.

Form supplied: Lyophilized powder. Your selections are carried into the quote request automatically.

Overview

Thymosin alpha-1 (thymalfasin) is a 28-amino-acid peptide, N-terminally acetylated, corresponding to a fragment of the precursor protein prothymosin alpha. It was the first thymic peptide to be sequenced, and its defined structure (C129H215N33O55; 3108.3 g/mol) makes it a well-characterized immunomodulatory research peptide.

In preclinical and in-vitro research, thymosin alpha-1 has been studied for its effects on immune-cell signaling, including modulation of T-cell function and Toll-like-receptor-associated pathways. A chemically synthesized form identical to human thymosin alpha-1 has been approved in a number of countries as an immunomodulating therapeutic in specific indications; that approval status is contextual background and is distinct from the research-only material offered here.

BioTech Pharma supplies Thymosin alpha-1 as a lyophilized powder intended solely for laboratory research; it is not offered for human or veterinary use. Lot-specific analytical documentation may be available and should be confirmed for the applicable material.

Research Applications

  • Immune-cell signaling and T-cell modulation studies
  • Toll-like-receptor pathway research
  • Cytokine-response and inflammation models
  • Prothymosin-alpha fragment structure–function work
  • Tissue-response and host-defense research models

Frequently Asked Questions

Scientific References

Analytical Data

Lot-specific documentation may be available for the applicable material and must be confirmed per enquiry. Where available, it may include:

  • HPLC purity result
  • LC-MS identity confirmation
  • Appearance
  • Net content

Request the records you need with your quote and we will confirm availability for your batch.

Procurement Details

Availability, lead time, salt / content basis, and cold-chain requirements depend on the specific lot and quantity, so we confirm them per enquiry rather than publishing fixed figures. Request confirmation for your requirements with your quote and our team will respond with details for the applicable batch.

Storage & Handling

Lyophilized: store sealed at −20 °C, protected from light and moisture. Reconstituted solutions should be kept refrigerated (2–8 °C); prepared-solution stability is lot-specific and should be determined empirically for each application. Prepared-solution stability should be confirmed for the applicable material.

Related Compounds